澳優(01717.HK):上半年EBITDA為3.64億元 同比增長5.5%
格隆匯8月25日丨澳優(01717.HK)發佈公吿,截至2023年6月30日止六個月,實現收入人民幣35.12億元,同比下降3.7%;毛利人民幣14.73億元,同比下降15.0%;EBITDA為人民幣3.64億元,同比增長5.5%;歸屬於公司權益持有人的利潤人民幣1.85億元,同比下降10.3%;每股基本盈利人民幣10.25分。
2023年上半年,面對具大挑戰的環境下,集團錄得收入同比輕微下降或3.7%。其中自家品牌配方牛奶粉業務經過2022年的調整,2023年上半年初現成效,收入同比提升2.4%,錄得人民幣12.616億元。此外,得益於新冠疫情後經濟恢復及集團於海外多年的深耕佈局及發展,自家品牌配方羊奶粉(“佳貝艾特”)海外業務延續2022年的增長勢頭,2023年中期期間錄得同比117.5%的增長。上述增長被佳貝艾特於中國的銷售額下滑抵銷,而佳貝艾特的銷售額下滑主要由於中國出生率下降令市場競爭激烈,以及於2023年上半年增加折扣清理舊品牌悠裝庫存所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.